Multimodal strategy for reduction of homologous transfusions in cranio-maxillofacial surgery.
The transfusion of homologous blood carries well-known risks that have prompted efforts to develop alternative techniques. Such measures are of particular interest to patients undergoing elective procedures. A total of 204 patients, out of 1470 patients who consecutively underwent major craniomaxillofacial procedures under general anesthesia over a two-year period, were enrolled in a prospective protocol to reduce homologous transfusion requirements when a blood loss in excess of 500 ml was anticipated. The data were compared with the results of a retrospective control group (n=2890) covering major procedures during the previous four years, when blood-saving measures were applied occasionally, but not based on a global strategy. Techniques for the reduction of homologous transfusions were acute normovolemic hemodilution, controlled moderate hypotension, cell saver and predeposit autologous blood. In addition, preoperative administration of human recombinant erythropoietin was introduced during the last year of the study. These techniques were applied individually or in combination, depending on contraindications specific for each technique, using invasive monitoring in order to maintain intraoperative hemodynamic stability. The goal of this study was to examine the extent to which homologous transfusions may be reduced with the systematic application of transfusion-sparing techniques. Of 204 patients qualifying for the transfusion-sparing protocol, 30 received homologous transfusions. In comparison to the control group, utilization of transfusion-sparing techniques had doubled. The overall reduction in the use of homologous transfusions was highly significant. When acute normovolemic hemodilution, controlled moderate hypotension and the cell saver were used in combination, a greater reduction in homologous transfusions was achieved than with the use of either a single modality or combination of any two. No transfusions were required in patients pretreated with erythropoietin.
Rohling
R G
RG
Department of Cranio-Maxillofacial Surgery, University Hospital Zurich, Switzerland.
Haers
P E
PE
Zimmermann
A P
AP
Schanz
U
U
Marquetand
R
R
Sailer
H F
HF
D000293:Adolescent; D000328:Adult; D000368:Aged; D001803:Blood Transfusion / Q000706:statistics & numerical data / Q000639:trends*; D001804:Blood Transfusion, Autologous; D002648:Child; D005260:Female; D006438:Hemodilution; D006801:Humans; D007023:Hypotension, Controlled; D007430:Intraoperative Care; D008297:Male; D008875:Middle Aged; D019647:Oral Surgical Procedures; D011182:Postoperative Care; D012886:Skull / Q000601:surgery*